The Sulfamethoxazole and Trimethopri, cataloged under National Stock Number 6505-01-169-3658, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Roche Laboratories Inc.. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 10 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 2 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-169-3658 |
| Primary Part Number | 72492 |
| Item Name | Sulfamethoxazole and Trimethopri |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Roche Laboratories Inc. |
| Status | ACTIVE |
| Administration | INTRAVENOUS INFUSION |
| Primary Container Content Quantity | 10.000 MILLILITERS |
| Supplementary Features | MEDSEP ITEM FOR DOD,BURROUGHS WELLCOME |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Active Medicament Medicinal Strength | 80.000 MILLIGRAMS SULFAMETHOXAZOLE PER MILLILITER AND 16.000 MILLIGRAMS TRIMETHOPRIM PER MILLILITER |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| 72492 PRIMARY | Roche Laboratories Inc. (USA) |
| NDC00703-9514-03 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| SULFAMETHOPRIM | 5/9 Secondary reference Quad Pharmaceuticals Inc |
| BACTRIM I.V. INFUSION | 5/1 Secondary reference Roche Laboratories Inc. |
| NDC00173-0856-95 | 5/9 Secondary reference Burroughs Wellcome Co |
| BACTRIM | 5/1 Secondary reference Roche Laboratories Inc. |
| NDC61570-0054-10 | 5/9 Secondary reference Monarch Pharmaceuticals Inc |
| SEPTRA I.V. INFUSION | 5/9 Secondary reference Burroughs Wellcome Co |
| SEPTRA | 5/9 Secondary reference Burroughs Wellcome Co |
| NDC00641-2765-43 | 5/9 Secondary reference Elkins-Sinn Inc |
| SULFAMETHOPRIM INJECTION | 5/9 Secondary reference Quad Pharmaceuticals Inc |
| NDC00081-0856-95 | 5/9 Secondary reference Burroughs Wellcome Co |
NSN 6505-01-169-3658 is a Sulfamethoxazole and Trimethopri, manufactured by Roche Laboratories Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-169-3658 has 2 manufacturer part numbers on file: 72492 (Roche Laboratories Inc.), NDC00703-9514-03 (Teva Pharmaceuticals Usa, Inc.).
2 possible matches (shared part number, not a government interchangeability claim): 6505-01-186-8161, 6505-01-216-1828. Verify interchangeability with system specifications before substitution.
Key specifications for 72492: Administration: INTRAVENOUS INFUSION; Primary Container Content Quantity: 10.000 MILLILITERS; Supplementary Features: MEDSEP ITEM FOR DOD,BURROUGHS WELLCOME; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.